Post-approval studies (Phase 4)UnknownNCT03006003What this trial is testingOsteoporosis Treatment in Post-menopausal WomenWho this might be right forDepressive Syndrome Taichung Veterans General Hospital 500
Large-scale testing (Phase 3)Study completedNCT00172172What this trial is testingCalcium Supplementation in Postmenopausal WomenWho this might be right forOsteoporosis Shire 374
Large-scale testing (Phase 3)Study completedNCT00543218What this trial is testingPTH Comparison in Post Menopausal WomenWho this might be right forOsteoporosis, Post-Menopausal Eli Lilly and Company 63
Post-approval studies (Phase 4)Study completedNCT00503113What this trial is testingBonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.Who this might be right forPost-Menopausal Osteoporosis Hoffmann-La Roche 801
Early research (Phase 1)Ended earlyNCT02337387What this trial is testing2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal WomenWho this might be right forOsteoporosis, Postmenopausal Eli Lilly and Company 28
Not applicableStudy completedNCT03503552What this trial is testingBody Composition and Risk for Development of Pre-diabetes in Post-menopausal Chinese Women in SingaporeWho this might be right forOsteoporosisMetabolic Syndrome JeyaKumar Henry 97
Not applicableStudy completedNCT06081764What this trial is testingInvestigation of the Effects of Physical Activity in Women at Risk of OsteoporosisWho this might be right forOsteoporosis Risk Pamukkale University 40
Testing effectiveness (Phase 2)Study completedNCT00165204What this trial is testingEffects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic OophorectomyWho this might be right forMenopausePostmenopausal Bone LossBreast Cancer Dana-Farber Cancer Institute 50
Post-approval studies (Phase 4)Study completedNCT00489424What this trial is testingAcetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone MassWho this might be right forOsteoporosis Novartis Pharmaceuticals 793
Not applicableStudy completedNCT00891553What this trial is testingCR9112792, a Follow-up of Study CR9108963Who this might be right forOsteoporosis GlaxoSmithKline 171
Testing effectiveness (Phase 2)Ended earlyNCT00471237What this trial is testingA Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.Who this might be right forOsteoporosis GlaxoSmithKline 564
Post-approval studies (Phase 4)Study completedNCT00431444What this trial is testingEffects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral DensityWho this might be right forOsteoporosis Novartis 110
Post-approval studies (Phase 4)Study completedNCT00545480What this trial is testingSUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.Who this might be right forPost Menopausal Osteoporosis Hoffmann-La Roche 596
Large-scale testing (Phase 3)Study completedNCT00355953What this trial is testingVascular and Skeletal Protective Effects of Genistein in Postmenopausal WomenWho this might be right forMenopauseOsteopenia University of Messina 400
Post-approval studies (Phase 4)Study completedNCT00532428What this trial is testingLong Term Effects of Raloxifene Treatment on Bone QualityWho this might be right forOsteoporosis, Post-Menopausal Eli Lilly and Company 31